Trifolirhizin inhibits proliferation, migration and invasion in nasopharyngeal carcinoma cells via PI3K/Akt signaling pathway suppression

被引:10
|
作者
Jiang, Xing [1 ]
Yin, Haihui [2 ]
Su, Wenqing [3 ]
Quan, Haiyan [4 ]
Yuan, Xinye [1 ]
Feng, Xu [1 ]
Li, Pei [1 ]
He, Yan [1 ]
Xiao, Junhui [1 ]
Li, Rong [1 ]
机构
[1] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Pharm, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Med Ultrasound, Hengyang 421001, Hunan, Peoples R China
[3] Youjiang Med Univ Nationalities, Baise 533000, Guangxi, Peoples R China
[4] Hunan Polytech Environm & Biol, Hengyang 421001, Hunan, Peoples R China
关键词
Nasopharyngeal carcinoma; Proliferation; Migration; Invasion; Signaling pathway; SOPHORA-FLAVESCENS; MEDICINE; CANCER;
D O I
10.1016/j.bbrc.2023.05.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nasopharyngeal carcinoma (NPC) is a highly recurrent and metastatic malignant tumor affecting a large number of individuals in southern China. Traditional Chinese herbal medicine has been found to be a rich source of natural compounds with mild therapeutic effects and minimal side effects, making them increasingly popular for treating various diseases. Trifolirhizin, a natural flavonoid derived from legu-minous plants, has gained significant attention for its therapeutic potential. In this study, we confirmed that trifolirhizin could effectively inhibit the proliferation, migration and invasion of nasopharyngeal carcinoma 6-10B and HK1 cells. Furthermore, our findings demonstrated that trifolirhizin achieves this by suppressing the PI3K/Akt signaling pathway. The findings of the present study provides a valuable perspective on the potential therapeutic applications of trifolirhizin for the treatment of nasopharyngeal carcinoma.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [31] TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway
    Sun, Tianshui
    Bi, Fangfang
    Liu, Zhuonan
    Yang, Qing
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [32] SASH1 inhibits proliferation and invasion of thyroid cancer cells through PI3K/Akt signaling pathway
    Sun, Dawei
    Zhou, Rui
    Liu, Huamin
    Sun, Wenhai
    Dong, Anbing
    Zhang, Hongmei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12276 - 12283
  • [33] β-Escin inhibits the proliferation of osteosarcoma cells via blocking the PI3K/Akt pathway
    Zhu, Minyu
    Ying, Jinwei
    Lin, Chaowei
    Wang, Yu
    Huang, Kelun
    Zhou, Yang
    Teng, Honglin
    RSC ADVANCES, 2018, 8 (52): : 29637 - 29644
  • [34] RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway
    Li, Hongxia
    Cao, Guangming
    Zhang, Nawei
    Lou, Tong
    Wang, Qiushi
    Zhang, Zhenyu
    Liu, Chongdong
    MOLECULAR MEDICINE REPORTS, 2018, 18 (03) : 2873 - 2879
  • [35] Punicic Acid Inhibits Glioblastoma Migration and Proliferation via the PI3K/AKT1/mTOR Signaling Pathway
    Mete, Mesut
    Unsal, Ulkun U.
    Aydemir, Isil
    Sonmez, Pinar K.
    Tuglu, Mehmet, I
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (09) : 1120 - 1131
  • [36] Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway
    Li, Z-Z
    Wang, Y-L
    Yu, Y-H
    Xing, Y-L
    Ji, X-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (01) : 105 - 112
  • [37] Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway
    Wang, Rong
    Li, Rizhao
    Yang, Huibing
    Chen, Xuejiao
    Wu, Liangliang
    Zheng, Xiaohui
    Jin, Yuepeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
  • [38] Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway
    Rong Wang
    Rizhao Li
    Huibing Yang
    Xuejiao Chen
    Liangliang Wu
    Xiaohui Zheng
    Yuepeng Jin
    Journal of Cancer Research and Clinical Oncology, 150
  • [39] UNBS5162 inhibits colon cancer growth via suppression of PI3K/Akt signaling pathway
    Zhang, Fan
    Lv, Hui-zeng
    Liu, Ji-ming
    Ye, Xiao-yong
    Wang, Cun-chuan
    M S-MEDECINE SCIENCES, 2018, 34 : 99 - 104
  • [40] Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway
    Zhang, Luquan
    Liang, Hao
    Xin, Yanzhong
    ANTI-CANCER DRUGS, 2020, 31 (08) : 847 - 855